| Dr Clara Baccini Jauregui, MD | |
|
4791 W 4th Ave, Hialeah, FL 33012-3938 | |
| (305) 570-2225 | |
| (305) 899-0411 |
| Full Name | Dr Clara Baccini Jauregui |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 23 Years |
| Location | 4791 W 4th Ave, Hialeah, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891961421 | NPI | - | NPPES |
| 022-462-200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME107797 (Florida) | Primary |
| Entity Name | Project Access Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427270412 PECOS PAC ID: 6204825433 Enrollment ID: O20040511001424 |
News Archive
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that it has agreed to acquire the Singapore-based company ES Cell International Pte Ltd.
The team of Professor Burkhard Luy from KIT and Junior Professor Stefan F. Kirsch from the TUM has now shown for the first time that certain NMR parameters, the so-called residual dipolar couplings, can make a significant contribution towards determining the constitution of chemical compounds when traditional methods fail.
Health care providers increasingly are embracing payment systems - based on ideas such as bundled payments, accountable care organizations and medical homes - that reimburse based on treatment as a whole rather than the fee-for-service model.
The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes.
› Verified 4 days ago
| Entity Name | Comprehensive Medical Access (cma) Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316174113 PECOS PAC ID: 5698812634 Enrollment ID: O20091024000048 |
News Archive
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that it has agreed to acquire the Singapore-based company ES Cell International Pte Ltd.
The team of Professor Burkhard Luy from KIT and Junior Professor Stefan F. Kirsch from the TUM has now shown for the first time that certain NMR parameters, the so-called residual dipolar couplings, can make a significant contribution towards determining the constitution of chemical compounds when traditional methods fail.
Health care providers increasingly are embracing payment systems - based on ideas such as bundled payments, accountable care organizations and medical homes - that reimburse based on treatment as a whole rather than the fee-for-service model.
The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes.
› Verified 4 days ago
| Entity Name | Clara Baccini Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033492723 PECOS PAC ID: 9537305529 Enrollment ID: O20130417000548 |
News Archive
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that it has agreed to acquire the Singapore-based company ES Cell International Pte Ltd.
The team of Professor Burkhard Luy from KIT and Junior Professor Stefan F. Kirsch from the TUM has now shown for the first time that certain NMR parameters, the so-called residual dipolar couplings, can make a significant contribution towards determining the constitution of chemical compounds when traditional methods fail.
Health care providers increasingly are embracing payment systems - based on ideas such as bundled payments, accountable care organizations and medical homes - that reimburse based on treatment as a whole rather than the fee-for-service model.
The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clara Baccini Jauregui, MD 13290 Keystone Ter, North Miami, FL 33181-2254 Ph: (305) 570-2225 | Dr Clara Baccini Jauregui, MD 4791 W 4th Ave, Hialeah, FL 33012-3938 Ph: (305) 570-2225 |
News Archive
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that it has agreed to acquire the Singapore-based company ES Cell International Pte Ltd.
The team of Professor Burkhard Luy from KIT and Junior Professor Stefan F. Kirsch from the TUM has now shown for the first time that certain NMR parameters, the so-called residual dipolar couplings, can make a significant contribution towards determining the constitution of chemical compounds when traditional methods fail.
Health care providers increasingly are embracing payment systems - based on ideas such as bundled payments, accountable care organizations and medical homes - that reimburse based on treatment as a whole rather than the fee-for-service model.
The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes.
› Verified 4 days ago
Onix Cesar Garib Alpizar, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2140 W 68th St Ste 300, Hialeah, FL 33016 Phone: 305-822-4107 Fax: 305-822-5086 | |
Aaron Rodas, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1475 W 49th Pl, Hialeah, FL 33012 Phone: 305-558-2500 | |
Mary Jo Villar, D.O. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 7600 W 20th Ave, Ste 103-104, Hialeah, FL 33016 Phone: 305-231-3150 Fax: 305-231-5020 | |
Francisco J Dieguez Jr., MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 145 E 49th St, Hialeah, FL 33013 Phone: 305-575-1776 Fax: 305-575-1780 | |
Miguel A. Diaz, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7100 W 20th Ave Ste 205, Hialeah, FL 33016 Phone: 305-817-1344 Fax: 305-817-1355 | |
Reynier Pomares Castillo, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 5961 Nw 173rd Dr, Hialeah, FL 33015 Phone: 305-556-7500 Fax: 305-851-5708 | |
Manuel Suarez, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1435 W 49th Pl, Suite 207, Hialeah, FL 33012 Phone: 305-556-8556 Fax: 305-556-6112 |